Delivery Order SPE2DB22D2005-SPE2DB25FJGT6
Award Date
1/28/25
Potential Completion Date
1/29/25
Potential Value
$4.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Ketorolac 0.4% ophthalmic solution, a prescription eye medication, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on a firm fixed-price basis for a total ceiling value of $2,047.08. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 2025. This...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract valued at $7,542.83 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4564247323 - Ketorolac 0.5% Ophthalmic Solution 5ML. The contract has an ultimate completion date of April 12, 2024. This delivery order is issued under Amerisourcebergen's single-award indefinite delivery contract with DLA valued up to $999,999,999.00 through December 31, 2025, which serves...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of ketorolac 0.5% ophthalmic solution in 10 ml bottles. The $3,564.79 Firm Fixed Price Delivery Order was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense, on April 15, 2024, with a planned completion date of April 16, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award, with an identifier of SPE2DB22D3016|SPE2DB24FBDJ4, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Ketorolac 0.4% ophthalmic solution, a medication used to treat eye pain and inflammation. It is a firm-fixed-price delivery order contract with a ceiling value of $1,114.09 and a completion date of August 9, 2024. The contract does not have a set-aside designation....
This federal contract award is a delivery order with a firm fixed price of $1,125.12 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of 4566736695 - Ketorolac 0.5% Ophthalmic Solution, 5 mL, with a period of performance through December 17, 2024. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
The U.S. government awarded a Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to federal agencies. The $1,626.86 Firm Fixed Price contract is for the delivery of Ketorolac 0.5% ophthalmic solution, a medication used to treat eye pain and inflammation. This contract is associated with a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the Defense...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of Ketorolac 0.5% Ophth Solution 5ML, a prescription medication, with a firm fixed price ceiling value of $1,987.18 and a performance period through May 29, 2025. The contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp is the prime contractor and there are no subcontractors...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA), which provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. The $6,901.75 Delivery Order was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the federal government, including the Department of Defense (DoD) and Veterans Affairs (VA). The...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,340.64 Firm Fixed Price Delivery Order is for the supply of 4564662080 ! KETOROLAC 0.5% OPHTH SOLUTION 5ML, with a period of performance ending on May 21, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
The Defense Logistics Agency awarded a $38,670 delivery order to Amerisourcebergen Drug Corporation for ketorolac ophthalmic solution. As the prime contractor, Amerisourcebergen will supply 5mL bottles of the 0.5% strength ophthalmic solution to meet DLA requirements. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one-day period from September 6-7, 2023. The firm fixed price contract was awarded utilizing Amerisourcebergen's position on an existing...